Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Intervalo de año de publicación
1.
Redox Biol ; 68: 102944, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37890359

RESUMEN

AIMS: Endothelial dysfunction plays a pivotal role in atherosclerosis, but the detailed mechanism remains incomplete understood. Nogo-B is an endoplasmic reticulum (ER)-localized protein mediating ER-mitochondrial morphology. We previously showed endothelial Nogo-B as a key regulator of endothelial function in the setting of hypertension. Here, we aim to further assess the role of Nogo-B in coronary atherosclerosis in ApoE-/- mice with pressure overload. METHODS AND RESULTS: We generated double knockout (DKO) mouse models of systemically or endothelium-specifically excising Nogo-A/B gene on an ApoE-/- background. After 7 weeks of transverse aortic constriction (TAC) surgery, compared to ApoE-/- mice DKO mice were resistant to the development of coronary atherosclerotic lesions and plaque rapture. Sustained elevation of Nogo-B and adhesion molecules (VCAM-1/ICAM-1), early markers of atherosclerosis, was identified in heart tissues and endothelial cells (ECs) isolated from TAC ApoE-/- mice, changes that were significantly repressed by Nogo-B deficiency. In cultured human umbilical vein endothelial cells (HUVECs) exposure to inflammatory cytokines (TNF-α, IL-1ß), Nogo-B was upregulated and activated reactive oxide species (ROS)-p38-p65 signaling axis. Mitofusin 2 (Mfn2) is a key protein tethering ER to mitochondria in ECs, and we showed that Nogo-B expression positively correlated with Mfn2 protein level. And Nogo-B deletion in ECs or in ApoE-/- mice reduced Mfn2 protein content and increased ER-mitochondria distance, reduced ER-mitochondrial Ca2+ transport and mitochondrial ROS generation, and prevented VCAM-1/ICAM-1 upregulation and EC dysfunction, eventually restrained atherosclerotic lesions development. CONCLUSION: Our study revealed that Nogo-B is a critical modulator in promoting endothelial dysfunction and consequent pathogenesis of coronary atherosclerosis in pressure overloaded hearts of ApoE-/- mice. Nogo-B may hold the promise to be a common therapeutic target in the setting of hypertension.


Asunto(s)
Aterosclerosis , Enfermedad de la Arteria Coronaria , Hipertensión , Placa Aterosclerótica , Humanos , Animales , Ratones , Enfermedad de la Arteria Coronaria/genética , Enfermedad de la Arteria Coronaria/metabolismo , Molécula 1 de Adhesión Intercelular/genética , Molécula 1 de Adhesión Intercelular/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Molécula 1 de Adhesión Celular Vascular/genética , Molécula 1 de Adhesión Celular Vascular/metabolismo , Proteínas Nogo/genética , Proteínas Nogo/metabolismo , Aterosclerosis/genética , Aterosclerosis/metabolismo , Placa Aterosclerótica/metabolismo , Estrés Oxidativo , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Inflamación/metabolismo , Endotelio/metabolismo , Hipertensión/metabolismo , Apolipoproteínas E/genética , Ratones Noqueados , Ratones Endogámicos C57BL
2.
Chin J Integr Med ; 25(6): 454-461, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28795389

RESUMEN

OBJECTIVE: To explore the anti-nociceptive effect of patchouli alcohol (PA), the essential oil isolated from Pogostemon cablin (Blanco) Bent, and determine the mechanism in molecular levels. METHODS: The acetic acid-induced writhing test and formalin-induced plantar injection test in mice were employed to confirm the effect in vivo. Intracellular calcium ion was imaged to verify PA on mu-opioid receptor (MOR). Cyclooxygenase 2 (COX2) and MOR of mouse brain were expressed for determination of PA's target. Cellular experiments were carried out to find out COX2 and MOR expression induced by PA. RESULTS: PA significantly reduced latency period of visceral pain and writhing induced by acetic acid saline solution (P<0.01) and allodynia after intra-plantar formalin (P<0.01) in mice. PA also up-regulated COX2 mRNA and protein (P<0.05) with a down-regulation of MOR (P<0.05) both in in vivo and in vitro experiments, which devote to the analgesic effect of PA. A decrease in the intracellular calcium level (P<0.05) induced by PA may play an important role in its anti-nociceptive effect. PA showed the characters of enhancing the MOR expression and reducing the intracellular calcium ion similar to opioid effect. CONCLUSIONS: Both COX2 and MOR are involved in the mechanism of PA's anti-nociceptive effect, and the up-regulation of the receptor expression and the inhibition of intracellular calcium are a new perspective to PA's effect on MOR.


Asunto(s)
Analgésicos/farmacología , Ciclooxigenasa 2/metabolismo , Receptores Opioides mu/metabolismo , Sesquiterpenos/farmacología , Ácido Acético , Analgésicos/administración & dosificación , Analgésicos/uso terapéutico , Animales , Calcio/metabolismo , Línea Celular , Citoplasma/metabolismo , Hiperalgesia/complicaciones , Hiperalgesia/tratamiento farmacológico , Mediadores de Inflamación/metabolismo , Iones , Masculino , Ratones Endogámicos ICR , Células PC12 , Ratas , Sesquiterpenos/administración & dosificación , Sesquiterpenos/uso terapéutico
3.
Chin J Nat Med ; 15(3): 178-191, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28411686

RESUMEN

Heat stress can stimulate an increase in body temperature, which is correlated with increased expression of heat shock protein 70 (HSP70) and tumor necrosis factor α (TNFα). The exact mechanism underlying the HSP70 and TNFα induction is unclear. Berberine (BBR) can significantly inhibit the temperature rise caused by heat stress, but the mechanism responsible for the BBR effect on HSP70 and TNFα signaling has not been investigated. The aim of the present study was to explore the relationship between the expression of HSP70 and TNFα and the effects of BBR under heat conditions, using in vivo and in vitro models. The expression levels of HSP70 and TNFα were determined using RT-PCR and Western blotting analyses. The results showed that the levels of HSP70 and TNFα were up-regulated under heat conditions (40 °C). HSP70 acted as a chaperone to maintain TNFα homeostasis with rising the temperature, but knockdown of HSP70 could not down-regulate the level of TNFα. Furthermore, TNFα could not influence the expression of HSP70 under normal and heat conditions. BBR targeted both HSP70 and TNFα by suppressing their gene transcription, thereby decreasing body temperature under heat conditions. In conclusion, BBR has a potential to be developed as a therapeutic strategy for suppressing the thermal effects in hot environments.


Asunto(s)
Berberina/farmacología , Proteínas HSP70 de Choque Térmico/genética , Trastornos de Estrés por Calor/tratamiento farmacológico , TATA Box/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genética , Animales , Proteínas HSP70 de Choque Térmico/metabolismo , Trastornos de Estrés por Calor/genética , Trastornos de Estrés por Calor/metabolismo , Calor , Humanos , Masculino , Ratones , Ratones Endogámicos ICR , Factor de Necrosis Tumoral alfa/metabolismo
4.
Sci Rep ; 7: 45155, 2017 03 23.
Artículo en Inglés | MEDLINE | ID: mdl-28332601

RESUMEN

Transient Receptor Potential Melastatin-8 (TRPM8) reportedly plays a fundamental role in a variety of processes including cold sensation, thermoregulation, pain transduction and tumorigenesis. However, the role of TRPM8 in inflammation under cold conditions is not well known. Since cooling allows the convergence of primary injury and injury-induced inflammation, we hypothesized that the mechanism of the protective effects of cooling might be related to TRPM8. We therefore investigated the involvement of TRPM8 activation in the regulation of inflammatory cytokines. The results showed that TRPM8 expression in the mouse hypothalamus was upregulated when the ambient temperature decreased; simultaneously, tumor necrosis factor-alpha (TNFα) was downregulated. The inhibitory effect of TRPM8 on TNFα was mediated by nuclear factor kappa B (NFκB). Specifically, cold stress stimulated the expression of TRPM8, which promoted the interaction of TRPM8 and NFκB, thereby suppressing NFκB nuclear localization. This suppression consequently led to the inhibition of TNFα gene transcription. The present data suggest a possible theoretical foundation for the anti-inflammatory role of TRPM8 activation, providing an experimental basis that could contribute to the advancement of cooling therapy for trauma patients.


Asunto(s)
Respuesta al Choque por Frío/genética , Regulación de la Expresión Génica , Canales Catiónicos TRPM/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Biomarcadores , Encéfalo/metabolismo , Isquemia Encefálica/metabolismo , Calcio/metabolismo , Línea Celular , Humanos , Masculino , Ratones , Ratones Noqueados , FN-kappa B/metabolismo , Transporte de Proteínas , ARN Interferente Pequeño/genética , Canal Catiónico TRPA1/metabolismo
5.
Sci Rep ; 7: 41712, 2017 02 09.
Artículo en Inglés | MEDLINE | ID: mdl-28181523

RESUMEN

After being studied for approximately a century, berberine (BBR) has been found to act on various targets and pathways. A great challenge in the pharmacological analysis of BBR at present is to identify which target(s) plays a decisive role. In the study described herein, a rescue experiment was designed to show the important role of mitochondria in BBR activity. A toxic dose of BBR was applied to inhibit cell proliferation and mitochondrial activity, then α-ketobutyrate (AKB), an analogue of pyruvate that serves only as an electron receptor of NADH, was proven to partially restore cell proliferation. However, mitochondrial morphology damage and TCA cycle suppression were not recovered by AKB. As the AKB just help to regenerate NAD+, which is make up for part function of mitochondrial, the recovered cell proliferation stands for the contribution of mitochondria to the activity of BBR. Our results also indicate that BBR suppresses tumour growth and reduces energy charge and mitochondrial DNA (mtDNA) copy number in a HepG2 xenograft model. In summary, our study suggests that mitochondria play an important role in BBR activity regarding tumour cell proliferation and metabolism.


Asunto(s)
Berberina/farmacología , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Butiratos/metabolismo , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ciclo del Ácido Cítrico/efectos de los fármacos , ADN Mitocondrial , Relación Dosis-Respuesta a Droga , Dosificación de Gen , Humanos , Mitocondrias/genética , Mitocondrias/ultraestructura , NAD/metabolismo , Ácido Pirúvico/metabolismo
6.
Chin J Nat Med ; 14(5): 354-62, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27478098

RESUMEN

Brazilein is reported to have immunosuppressive effect on cardiovascular and cerebral-vascular diseases. The essential roles of innate immunity in cerebral ischemia are increasingly identified, but no studies concerning the influence of brazilein on the innate immunity receptors have been reported. The present study was designed to investigate the regulation of NOD2 (Nucleotide-binding oligomerization domain-containing protein 2) by brazilein for its protection of neuron in cerebral ischemia in vivo and oxygen-glucose deprivation in vitro. The results showed that brazilein could reverse the elevated expression of NOD2 and TNFα (tumor necrosis factor alpha) elicited by cerebral ischemia and reperfusion. This reduction could also be detected in normal mice and C17.2 cells, indicating that this suppressive effect of brazilein was correlated with NOD2. The results from GFP reporter plasmid assay suggested brazilein inhibited NOD2 gene transcription. In conclusion, brazilein could attenuate NOD2 and TNFα expression in cerebral ischemia and NOD2 may be one possible target of brazilein for its immune suppressive effect in neuro-inflammation.


Asunto(s)
Benzopiranos/administración & dosificación , Isquemia Encefálica/tratamiento farmacológico , Isquemia Encefálica/inmunología , Medicamentos Herbarios Chinos/administración & dosificación , Indenos/administración & dosificación , Neuronas/efectos de los fármacos , Proteína Adaptadora de Señalización NOD2/genética , Proteína Adaptadora de Señalización NOD2/metabolismo , Animales , Isquemia Encefálica/genética , Isquemia Encefálica/metabolismo , Células Cultivadas , Glucosa/metabolismo , Humanos , Masculino , Ratones , Ratones Endogámicos ICR , Neuronas/inmunología , Oxígeno/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología
7.
PLoS One ; 10(7): e0134044, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26226164

RESUMEN

The purpose of the present study is to confirm the protective effect of berberine (BBR) on gastrointestinal injury caused by acute heavy alcohol exposure, an effect that has not been reported previously. Our research details how BBR protects against gastrointestinal injuries from acute alcohol exposure using both in vivo and in vitro experiments. Acute high alcohol concentrations lead to obvious damage to the gastrointestinal mucosa, resulting in necrosis of the intestinal mucosa. Oral administration of BBR was able to significantly reduce this alcohol-induced damage, inhibit increases of alcohol-induced TNFα and IL-1ß expression in gastrointestinal mucosa as well as their upstream signals TLR2 and TLR4, and regulate cytokines that modulate tight junctions. Alcohol consumption is a popular human social behavior worldwide, and the present study reports a comprehensive mechanism by which BBR protects against gastrointestinal injuries from alcohol stress, providing people with a novel application of BBR.


Asunto(s)
Alcoholismo/complicaciones , Berberina/uso terapéutico , Mucosa Gástrica/efectos de los fármacos , Interleucina-1beta/fisiología , Mucosa Intestinal/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Receptor Toll-Like 2/fisiología , Factor de Necrosis Tumoral alfa/fisiología , Animales , Western Blotting , Células CACO-2/efectos de los fármacos , Mucosa Gástrica/patología , Células HEK293/efectos de los fármacos , Humanos , Interleucina-1beta/efectos de los fármacos , Mucosa Intestinal/patología , Masculino , Ratones , Ratones Endogámicos ICR , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptor Toll-Like 2/efectos de los fármacos , Factor de Necrosis Tumoral alfa/efectos de los fármacos
8.
Zhongguo Zhong Yao Za Zhi ; 39(16): 3142-7, 2014 Aug.
Artículo en Chino | MEDLINE | ID: mdl-25509303

RESUMEN

Pineapple (Ananas comosus) leaves contain mainly phenolic components with antioxidant and hypolipidemic effects. One of the principle components is p-coumaric acid. In this study, the transport behavior of p-coumaric acid, was observed after the administration of pineapple leaf phenols in vitro. Simultaneously, the effect of the phenols on glucose, total cholesterol and triglycerides transportation and metabolism in HepG2 cells was also observed. The results showed that the phenols had good transport characteristics. 5 min after the administration, p-coumaric acid of the phenols could be detected, and the content of p-coumaric acid reached the peak concentration after 60 min of the administration. p-coumaric acid of phenols have time-and dose-dependent manner. While promoting glucose transporter (GLUT4) and low density lipoprotein receptor (LDLR) expression, the phenols decreased intracellular lipid content. This reduction of intracellular lipid content was highly correlated with the promotion of lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) expression, while the reduction of intracellular glucose levels was correlated with glycogen synthesis in the cells.


Asunto(s)
Glucosa/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Extractos Vegetales/farmacología , Hojas de la Planta/química , Ananas/química , Transporte Biológico/efectos de los fármacos , Colesterol/metabolismo , Células Hep G2 , Humanos
9.
PLoS One ; 9(9): e108000, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25275506

RESUMEN

Brazilein, a natural small molecule, shows a variety of pharmacological activities, especially on nervous system and immune system. As a potential multifunctional drug, we studied the distribution and the transport behavior and metabolic behavior of brazilein in vivo and in vitro. Brazilein was found to be able to distribute in the mouse brain and transport into neural cells. A metabolite was found in the brain and in the cells. Positive and negative mode-MS/MS and Q-TOF were used to identify the metabolite. MS/MS fragmentation mechanisms showed the methylation occurred at the 10-hydroxyl of brazilein (10-O-methylbrazilein). Further, catechol-O- methyltransferase (COMT) was confirmed as a crucial enzyme correlated with the methylated metabolite generation by molecular docking and pharmacological experiment.


Asunto(s)
Benzopiranos/metabolismo , Indenos/metabolismo , Neuronas/metabolismo , Animales , Benzopiranos/administración & dosificación , Benzopiranos/química , Benzopiranos/farmacología , Transporte Biológico/efectos de los fármacos , Encéfalo/metabolismo , Catecol O-Metiltransferasa/química , Catecol O-Metiltransferasa/metabolismo , Muerte Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Complejo IV de Transporte de Electrones/antagonistas & inhibidores , Complejo IV de Transporte de Electrones/metabolismo , Indenos/administración & dosificación , Indenos/química , Indenos/farmacología , Masculino , Metilación/efectos de los fármacos , Ratones Endogámicos ICR , Neuronas/efectos de los fármacos , Células PC12 , Ratas , Reproducibilidad de los Resultados , Espectrometría de Masas en Tándem , Temperatura , Rayos Ultravioleta
10.
Eur J Pharmacol ; 708(1-3): 44-55, 2013 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-23499694

RESUMEN

Berberine acted as a natural medicine with multiple pharmacological activities. In the present study, we examined the effect of berberine against cerebral ischemia damage from cell cycle arrest and cell survival. Oxygen-glucose deprivation of PC12 cells and primary neurons, and carotid artery ligation in mice were used as in vitro and in vivo cerebral ischemia models. We found that the effect of berberine on cell cycle arrest during ischemia was mediated by decreased p53 and cyclin D1, increased phosphorylation of Bad (higher expression of p-Bad and higher ratio of p-Bad to Bad) and decreased cleavage of caspase 3. Meanwhile, berberine activated the PI3K/Akt pathway during the reperfusion, especially the phosphor-activation of Akt, to promote the cell survival. The neural protective effect of berberine was remained in the presence of inhibitor of mitogen-activated protein/extracellular signal-regulated kinase (MEK), but was suppressed by the inhibitors of PI3K and Akt. We demonstrated that berberine induced cell cycle arrest and cell survival to resist cerebral ischemia injury.


Asunto(s)
Berberina/farmacología , Isquemia Encefálica/metabolismo , Fármacos Neuroprotectores/farmacología , Daño por Reperfusión/metabolismo , Animales , Puntos de Control del Ciclo Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ciclina D1/genética , Ciclina D1/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Células PC12 , Fosfatidilinositol 3-Quinasas/genética , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/genética , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo
11.
PLoS One ; 8(1): e54234, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23335996

RESUMEN

The purpose of this study was to assess the effects of berberine (BBR) on thermoregulation in mice exposed to hot (40°C) and cold (4°C) environmental conditions. Four groups of mice were assembled with three different dosages of BBR (0.2, 0.4, and 0.8 mg/kg) and normal saline (control). In room temperature, our largest dosage of BBR (0.8 mg/kg) can reduce rectal temperatures (Tc) of normal mice. In hot conditions, BBR can antagonize the increasing core body temperature and inhibit the expression of HSP70 and TNFα in mice; conversely, in cold conditions, BBR can antagonize the decreasing core body temperature and enhance the expression of TRPM8. This study demonstrates the dual ability of BBR in maintaining thermal balance, which is of great relevance to the regulation of HSP70, TNFα and TRPM8.


Asunto(s)
Berberina/farmacología , Regulación de la Temperatura Corporal/efectos de los fármacos , Regulación de la Temperatura Corporal/fisiología , Frío , Calor , Animales , Berberina/administración & dosificación , Electrocardiografía , Regulación de la Expresión Génica/efectos de los fármacos , Proteínas HSP70 de Choque Térmico/antagonistas & inhibidores , Proteínas HSP70 de Choque Térmico/genética , Proteínas HSP70 de Choque Térmico/metabolismo , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Actividad Motora/genética , Canales Catiónicos TRPM/genética , Canales Catiónicos TRPM/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA